U.S. Markets closed
  • S&P 500

    +34.03 (+0.82%)
  • Dow 30

    +318.19 (+0.93%)
  • Nasdaq

    +50.42 (+0.37%)
  • Russell 2000

    +0.05 (+0.00%)
  • Crude Oil

    +0.22 (+0.34%)
  • Gold

    -0.50 (-0.03%)
  • Silver

    -0.06 (-0.23%)

    -0.0001 (-0.0121%)
  • 10-Yr Bond

    -0.0230 (-1.45%)
  • Vix

    -0.76 (-3.97%)

    +0.0004 (+0.0292%)

    -0.0410 (-0.0376%)

    -496.72 (-0.87%)
  • CMC Crypto 200

    -2.81 (-0.19%)
  • FTSE 100

    +36.87 (+0.52%)
  • Nikkei 225

    +518.74 (+1.80%)

COVID-19 Pandemic Mitigation Products Market - 2020-2024

Why trust and read this report? No one would have believed us if last Christmas we would have said that during April & May 2020 a devastating pandemic would kill every 10 days 58,000 people, as much as the total number of Americans killed during the ten-year Vietnam war.

New York, June 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "COVID-19 Pandemic Mitigation Products Market - 2020-2024" - https://www.reportlinker.com/p05915389/?utm_source=GNW
It devastated the global economy and created an unpredicted mega market.

As early as January 20, 2020 we recruited all our analysts to research the COVID-19 pandemic mitigation related products purchases. We interviewed hundreds of experts, participated in more than 95 conferences and webinars, reviewed more than 1,500 publications and interviewed executives of more than 65 pandemic related companies.

The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen detection, E-health, decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, medical devices and more. Our team members bring long term relations with the U.S. FDA and CDC as well as the EU CE and other national medical regulatory agencies.

We found that this virus has created a new market worth $251-$459 Billion* per annum – the COVID-19 Pandemic Mitigation Products and Services market. To adhere to our high standards of research, as nobody can forecast the future of the pandemic, we include in the report two scenarios:

  1. Optimistic scenario – assumes (among other things) that mass vaccination will commence by July 2021

  2. Conservative scenario – assumes (among other things) that no mass vaccination will be available until 2025

According to the COVID-19 Pandemic Mitigation Products Market – 2020-2024 report scenarios, the 2020-2024 cumulative market size is expected to be $1.4-$1.9 Trillion. The U.S. and Chinese markets will dominate the global one during the forecast period.

The 2024 COVID-19 Pandemic Mitigation Products Market (Scenario A), by Region

This 1020-page 5 volume market report is the first and most comprehensive review of the global COVID-19 Pandemic Mitigation Products & Services market available today. The objective of this report is to provide today’s strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market.

The COVID-19 Pandemic Mitigation Products Market – 2020-2024 report presents a thorough market analysis of 54 products & services, 6 vertical, 4 revenue source, 5 regional and 13 national markets. Furthermore, the report provides updated extensive data of 37 key vendors.

As countries start to re-open, and you do your best to recover your business, the report brings to your attention multi-billion business opportunities that may assist your struggle to retain business continuity and growth. This newly formed market is not limited to the healthcare supplier’s industry; many business opportunities are being created for industries from geo-surveillance to blockchain, from AI, big-data & deep learning to nonwoven fabrics.

Why Buy this Homeland Security Market Report?

A. Questions answered in this report include:

  • What is the COVID-19 Pandemic Mitigation Products & Services market size and what are the forecasted trends during 2020-2024?

  • What are the most attractive business opportunities?

  • What drives the customers to purchase solutions and services?

  • What are the COVID-19 Mitigation technology & services trends?

  • What is the 212 sub-markets size over the 2020-2024 period?

  • What are the challenges to market penetration & growth?

B. The COVID-19 Pandemic Mitigation Products Market size data is analyzed via 5 independent key perspectives.

With a highly fragmented market we address the “money trail” – each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:

  • By 54 Products and Services:

  1. Vaccines

  2. Therapeutic Drugs

  3. Other COVID-19 Pharma Industry Products

  4. PCR Instrumentation & Software

  5. Robotic PCR Systems & Software

  6. PCR Reagents & Consumables

  7. Nose & Mouth Swabs

  8. Self-collection PCR Test Kits

  9. Serologic Test Kits

  10. Standoff Thermometry

  11. X-Ray Procedures

  12. CT Procedures

  13. Ultrasound Procedures

  14. FDG-PET/CT Procedures & Wastewater Testing

  15. PACS & Teleradiology

  16. Medical PPE Gowns

  17. Medical Gloves

  18. Medical Face Masks

  19. Medical Face Shields

  20. Medical Eye Protection

  21. PPE Sterilization: Systems & Consumables

  22. Hand & Surface Sanitizers

  23. Decontamination

  24. Other Personal Protection Gear

  25. AI, Big Data & Deep Learning

  26. Homecare IT

  27. Geo-Surveillance Systems & Services

  28. E-Health

  29. Blockchain Technologies

  30. Other ICT

  31. Noninvasive Ventilators

  32. Invasive Mechanical Ventilators

  33. Next Generation Ventilators

  34. COVID-19 Homecare (HW, SW, Services)

  35. Portable Ventilators

  36. Surge Capacity Hospitals & ICUs

  37. Kidney Dialysis

  38. Extracorporeal Membrane Oxygenation Procedures

  39. Other Intensive Care Modalities

  40. PPE Gowns Manufacturing Plants

  41. Gloves Manufacturing Plants

  42. Face Masks Manufacturing Plants

  43. Face Shields Manufacturing Plants

  44. Serologic Test Kits Manufacturing Plants

  45. Melt-Blown PPE Fabric Manufacturing Plants

  46. Spun-Bond PPE Fabric Manufacturing Plants

  47. Self-collection PCR Test Kits Manufacturing Plants

  48. Ventilators Manufacturing Plants

  49. PCR Reagents Manufacturing Plants

  50. PCR Systems Manufacturing Plants

  51. Nose & Mouth Swabs Manufacturing Plants

  52. Medical Glass & Other Manufacturing Plants

  53. R&D Equipment & Consumables

  54. Medical Glass and Other Products & Services

  • By 6 Vertical Market:

  1. Hospitals and Surge Hospitals

  2. Clinical Labs

  3. Clinics

  4. Emergency Medical Services (EMS)

  5. Homecare & Nursing Homes

  6. Research Bodies

  • By 13 National Markets:

  1. U.S.A

  2. Canada

  3. UK

  4. Germany

  5. France

  6. Italy

  7. Rest of Europe

  8. India

  9. China

  10. South Korea

  11. Japan

  12. Rest of Asia Pacific

  13. RoW

  • By 5 Regional Markets:

  1. North America

  2. Latin America

  3. Europe

  4. Middle East & Africa

  5. Asia Pacific

  • By 4 Revenue Source Markets:

  1. Product Sales

  2. Training Services

  3. Planning & Consulting

  4. Maintenance & Upgrades

C. Detailed market analysis frameworks for each of the market sectors are provided, including:

  1. Market drivers & inhibitors

  2. Business opportunities

  3. SWOT analysis

  4. Competitive analysis for each of the 54 products and services that covers:

    1. Barriers to Entry

    2. Supplier Power

    3. Buyer Power

    4. Barriers to Substitution.

  5. Business environment

  6. The 2020-2024 market segmented into 212 submarkets

D. The report provides an updated extensive data of the leading 37 companies (including companies’ profile, recent annual revenues, COVID-19 mitigation activities & products and contact information).

E. The report includes over 2300 links to the COVID-19 Pandemic Mitigation community information sources

F. The report mentions > 450 Vendors including the following:

3M Company, 3Scan, Abbott , AbCellera, Advenio Technosys, Agfa Healthcare, Agilent Technologies, AiCure, Aindra, Allscripts Healthcare Solutions, Amara Health Analytics , Amazon , analyticsMD, Apixio, Apple, Arterys Inc, Atlas Wearables, Atomwise, Avalon Nutrition VITL, Babylon Health, Bay Labs, Behold.ai, benevolent.ai, BIOBEATS, BlueDot, Bollé Safety, Bullard, Buoy Health, Care Angel Wearables QorQL, Careskore, Clinithink, Cloud Pharmaceuticals, CloudMedx, CureMetrix Mental health Ginger.io, Cyrcadia, Deep 6 AI, Deep Genomics, Dell Technologies Inc., Delta Plus Group, Desktop Genetics Virtual mate Ada Health, DreaMed Diabetes, Dupont, EaglEyeMed, Eli Lilly, Encon Safety Products, Enlitic, EnsoData, Entopsis, Envisagenics Research iCarbonX, ERB Industries Inc., Ergodyne, Essilor of America, Flashback Technologies, Flow Health, Ford, Freenome, Frequency Therapeutics Inc., Fujifilm Holdings Corporation, Gateway Safety Inc., GE Healthcare, General Electric, General Motors, General Vision, Gentex Corporation, Gibco, Gilead Sciences, Globavir Biosciences, Google, Healint, Health Fidelity, HealthNextGen, HexArmor, Hindsait, Honeywell Safety Products, IBM, Imagen Technologies, Imagia Cybernetics, Infermedica, Infervision, Inovio Pharmaceuticals, Inside DNA, InSilico Medicine, Intel Corporation, Intendu, Invitrogen, Ion Torrent, Ironwear, Johnson & Johnson (Janssen), Jvion, Kapa Biosystems, Keen Eye Technologies, Kimberly-Clark Professional, Koninklijke Philips NV, Lexmark International Inc., LifeGraph, Lucina Health, Lumiata, Lunit, Lytics, Magnea, Maxim Biotech, Maxwell MRI, McKesson Corporation, MCR Safety, Medal, Medalogix, Medasense, MedAware, Medtronic, MedWhat, MedyMatch , Merck, Metabiota, Micron Technology, Microsoft Corporation, Mindshare Medical, Moderna, Morpheo, Niramai Health Analytix, Novarad Corporation, NuMedii, Numerate, Nuritas Pharma Turbine, Nvidia Corporation, Oncora Medical, Ovuline, PeerWell, Pfizer, Philips, Philips Healthcare, PhysIQ., Precision Health Intelligence, Predible Health, Profility, Proscia, pulseData, Pyramex Safety, Qualaris Healthcare Solutions, Qualcomm Incorporated, Qualcomm Incorporated, Qure. Ai, Radians Inc., Recursion Pharmaceuticals, Regeneron Pharmaceuticals, Roam Analytics , Roche, RxPREDICT, Safety Optical Service, Samsung Electronics Co., Ltd, Sanofi, Saykara, Sellstrom Manufacturing Company (SureWerx), Sense.ly, Sensory Inc., Siemens, Sigma-Aldrich Corp., Skymind Inc., Thermo Fisher Scientific, Toshiba, Vir Biotechnology Inc., VisionAid Inc., WuXi Biologics, Xilinx Inc..

G. COVID-19 Pandemic Mitigation Products & Services Market report includes 24 appendices:

  1. Appendix 1: Differences & Similarities Between Common Flu and Coronavirus

  2. Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel

  3. Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection

  4. Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns

  5. Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks

  6. Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators

  7. Appendix 7: CDC Adult Vaccine Price List

  8. Appendix 8: The CDC COVID-19 Bio-Safety Guidelines

  9. Appendix 9: The 2020 Global Desperation to Protect Medical Workers

  10. Appendix 10: Disinfection Procedures for COVID-19

  11. Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020

  12. Appendix 12: European Preparedness Against Emerging Epidemics

  13. Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19

  14. Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization

  15. Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)

  16. Appendix 16: Comparing Clinical COVID-19 Data by Nation

  17. Appendix 17: Home Healthcare IT

  18. Appendix 18: The Difference between PCR and Antibody Tests

  19. Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021

  20. Appendix 20: COVID-19 Tests

  21. Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region

  22. Appendix 22: Abbreviations

  23. Appendix 23: Glossary

  24. Appendix 24: Bibliography

Read the full report: https://www.reportlinker.com/p05915389/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001